| Hsa_circ_0001649: a circular RNA and potential novel biomarker for hepatocellular carcinoma M Qin, G Liu, X Huo, X Tao, X Sun, Z Ge, J Yang, J Fan, L Liu, W Qin Cancer Biomarkers 16 (1), 161-169, 2016 | 514 | 2016 |
| STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4 H Wang, X Huo, XR Yang, J He, L Cheng, N Wang, X Deng, H Jin, ... Molecular cancer 16, 1-15, 2017 | 503 | 2017 |
| Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study Q Shen, J Fan, XR Yang, Y Tan, W Zhao, Y Xu, N Wang, Y Niu, Z Wu, ... The lancet oncology 13 (8), 817-826, 2012 | 488 | 2012 |
| circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity B Li, L Zhu, C Lu, C Wang, H Wang, H Jin, X Ma, Z Cheng, C Yu, S Wang, ... Nature communications 12 (1), 295, 2021 | 411 | 2021 |
| Inducing and exploiting vulnerabilities for the treatment of liver cancer C Wang, S Vegna, H Jin, B Benedict, C Lieftink, C Ramirez, ... Nature 574 (7777), 268-272, 2019 | 353 | 2019 |
| Targeting vacuolar H+-ATPases as a new strategy against cancer S Fais, A De Milito, H You, W Qin Cancer research 67 (22), 10627-10630, 2007 | 330 | 2007 |
| Evolving therapeutic landscape of advanced hepatocellular carcinoma C Yang, H Zhang, L Zhang, AX Zhu, R Bernards, W Qin, C Wang Nature reviews Gastroenterology & hepatology 20 (4), 203-222, 2023 | 326 | 2023 |
| circTP63 functions as a ceRNA to promote lung squamous cell carcinoma progression by upregulating FOXM1 Z Cheng, C Yu, S Cui, H Wang, H Jin, C Wang, B Li, M Qin, C Yang, J He, ... Nature communications 10 (1), 3200, 2019 | 303 | 2019 |
| EGFR activation limits the response of liver cancer to lenvatinib H Jin, Y Shi, Y Lv, S Yuan, CFA Ramirez, C Lieftink, L Wang, S Wang, ... Nature 595 (7869), 730-734, 2021 | 281 | 2021 |
| Tumoral expression of IL-33 inhibits tumor growth and modifies the tumor microenvironment through CD8+ T and NK cells X Gao, X Wang, Q Yang, X Zhao, W Wen, G Li, J Lu, W Qin, Y Qi, F Xie, ... The Journal of Immunology 194 (1), 438-445, 2015 | 258 | 2015 |
| Increased serotonin signaling contributes to the Warburg effect in pancreatic tumor cells under metabolic stress and promotes growth of pancreatic tumors in mice SH Jiang, J Li, FY Dong, JY Yang, DJ Liu, XM Yang, YH Wang, MW Yang, ... Gastroenterology 153 (1), 277-291. e19, 2017 | 237 | 2017 |
| The growth and metastasis of human hepatocellular carcinoma xenografts are inhibited by small interfering RNA targeting to the subunit ATP6L of proton pump X Lu, W Qin, J Li, N Tan, D Pan, H Zhang, L Xie, G Yao, H Shu, M Yao, ... Cancer research 65 (15), 6843-6849, 2005 | 213 | 2005 |
| Elevated expression of DKK1 is associated with cytoplasmic/nuclear β-catenin accumulation and poor prognosis in hepatocellular carcinomas B Yu, X Yang, Y Xu, G Yao, H Shu, B Lin, L Hood, H Wang, S Yang, J Gu, ... Journal of hepatology 50 (5), 948-957, 2009 | 189 | 2009 |
| Long noncoding RNA miR503HG, a prognostic indicator, inhibits tumor metastasis by regulating the HNRNPA2B1/NF-κB pathway in hepatocellular carcinoma H Wang, L Liang, Q Dong, L Huan, J He, B Li, C Yang, H Jin, L Wei, C Yu, ... Theranostics 8 (10), 2814, 2018 | 181 | 2018 |
| Exosomes as a liquid biopsy for lung cancer S Cui, Z Cheng, W Qin, L Jiang Lung cancer 116, 46-54, 2018 | 176 | 2018 |
| Metabolism‐associated molecular classification of hepatocellular carcinoma C Yang, X Huang, Z Liu, W Qin, C Wang Molecular oncology 14 (4), 896-913, 2020 | 160 | 2020 |
| CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery XR Yang, Y Xu, B Yu, J Zhou, JC Li, SJ Qiu, YH Shi, XY Wang, Z Dai, ... Clinical Cancer Research 15 (17), 5518-5527, 2009 | 160 | 2009 |
| Synergistic cisplatin/doxorubicin combination chemotherapy for multidrug-resistant cancer via polymeric nanogels targeting delivery H Wu, H Jin, C Wang, Z Zhang, H Ruan, L Sun, C Yang, Y Li, W Qin, ... ACS applied materials & interfaces 9 (11), 9426-9436, 2017 | 151 | 2017 |
| A powerful drug combination strategy targeting glutamine addiction for the treatment of human liver cancer H Jin, S Wang, EA Zaal, C Wang, H Wu, A Bosma, F Jochems, N Isima, ... Elife 9, e56749, 2020 | 145 | 2020 |
| Gas6/Axl axis contributes to chemoresistance and metastasis in breast cancer through Akt/GSK-3β/β-catenin signaling C Wang, H Jin, N Wang, S Fan, Y Wang, Y Zhang, L Wei, X Tao, D Gu, ... Theranostics 6 (8), 1205, 2016 | 144 | 2016 |
